Containing Or Obtained From Leguminosae (e.g., Legumes Such As Soybean, Kidney Bean, Pea, Lentil, Licorice, Etc.) Patents (Class 424/757)
  • Patent number: 7740887
    Abstract: Disclosed are a concentrated beverage composition for hair health care, a method of manufacturing the concentrated beverage composition, and a natural tea comprising the same. The concentrated beverage composition for hair health care comprises 100 parts by weight of water, 10 to 20 parts by weight of Pleuropterus multiflorus extract, 5 to 20 parts by weight of Sophora flavescens extract, 1 to 5 parts by weight of black bean extract, 5 to 10 parts by weight of African black sesame extract; 1 to 10 parts by weight of pomegranate extract; 5 to 10 parts by weight of Oenothera odorata seeds extract; and 5 to 10 parts by weight of Sophora japonica extract.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: June 22, 2010
    Inventor: Young Joon Pak
  • Publication number: 20100150895
    Abstract: This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate, ?-Ketoglutarate and/or oxaloacetate, niacin/NADH, fruit extracts, anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains all natural substances that should mitigate many of the neurodegenerative processes known to be associated with PD. Mechanisms addressed are to prevent the loss of ATP/by 1-methyl-4-phenylpyridinium rotenone, scavenge hydrogen peroxide/O2.
    Type: Application
    Filed: February 6, 2010
    Publication date: June 17, 2010
    Inventors: Elizabeth Mazzio, Karam Soliman
  • Publication number: 20100143502
    Abstract: A plant wash comprising a mixture of dormant oil and hop extract in a carrier is useful for protecting fruit trees against freeze damage, bacterium, pest infestations, fungi and wilt.
    Type: Application
    Filed: November 23, 2009
    Publication date: June 10, 2010
    Inventor: Roger Rolland Ellis
  • Patent number: 7731995
    Abstract: Controlled studies demonstrate that methods using soy related peptides inhibit H3 acetylation, reduce expression of HMG CoA reductase and increase LDL receptor and Sp1 expression in mammals. The present disclosure is generally directed to using lunasin peptides and/or lunasin peptide derivatives to 1) inhibit H3 acetylation, 2) reduce expression of HMG CoA reductase, 3) increase LDL receptor expression or 4) increase Sp1 expression in a mammal. In at least one exemplary embodiment of the present disclosure, an effective amount of lunasin peptides or lunasin peptide derivatives and one or more enzyme inhibitors is provided to a mammal to 1) inhibit H3 acetylation, 2) reduce expression of HMG CoA reductase, 3) increase LDL receptor expression or 4) increase Sp1 expression in a mammal.
    Type: Grant
    Filed: September 16, 2006
    Date of Patent: June 8, 2010
    Inventor: Alfredo Flores Galvez
  • Patent number: 7713557
    Abstract: A natural oriental medicinal composition for the promotion of hair growth is provided. The oriental medicinal composition includes a black bean extract, a tangerine extract, a potato extract, a pine needle extract and a quartzite powder. Since the oriental medicinal composition includes crude drugs extracted from natural substances that can prevent hair loss, it is effective for hair growth and has ensured biostability. Particularly, the oriental medicinal composition allows newborn hair to grow in the form of stiff hair.
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: May 11, 2010
    Inventor: Hyeong Geun Choi
  • Patent number: 7700110
    Abstract: Disclosed is a composition comprising a combination of: Polygonum fagopyrum seed extract, Chlorella vulgaris extract, palmitoyl wheat protein hydrolysate, algae extract, and tripeptide. The composition may further comprise one or more of the following: Citrus unshiu peel extract, Sphacelaria scoparia extract, Bambusa vulgaris extract, Pisum sativum (pea) extract, Evodia rutaecarpa fruit extract, and dipalmitoylhydroxy proline. Such compositions are useful in methods for aiding in improving skin firmness, lifting the skin, preventing or decreasing skin sagging, and preventing or decreasing visible signs of aging resulting from internal and external causes such as environmental stresses.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: April 20, 2010
    Assignee: Access Business Group International LLC
    Inventors: Amy C. Zimmerman, Deborah A. O'Toole
  • Patent number: 7695727
    Abstract: A stick lip balm with efficacious amounts of natural moisturizer and organoleptic/sensory attributes of lip feel associated with moisturizers and emollients is provided. The lip balm of the invention comprises at least 90% botanically derived materials and can be formed into a stick sufficiently robust to substantially retain the stick shape under normal conditions of shipping, storage and usage. A method of making the stick lip balm is also provided.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: April 13, 2010
    Assignee: Wyeth LLC
    Inventors: Sara Vest Magee, John Oliver Bachert, Neil Partridge, Jay R. Dickerson
  • Publication number: 20100068273
    Abstract: A pharmaceutical formulation of a calcium salt and a dry plant extract in the form of a coated tablet, in which the formulation has a core of at least one dry plant extract, enveloped by at least one coating of at least one calcium salt. The plant extracts for the core may be selected from: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard lily); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (purple trefoil); Oenothera biennis hom. (primrose); Glycine soja (soy bean); Serenoa repens (saw-palmetto); Urtica dioica (stinging nettle), in particular its root; Cucurbita pepo (pumpkin), in particular its seed; Pygeum africanum; as well as suitable mixtures of these. Methods for the use of the formulation in treating osteoporosis and for manufacturing the formulation are provided.
    Type: Application
    Filed: November 12, 2009
    Publication date: March 18, 2010
    Applicant: BIONORICA AG
    Inventor: Michael A. Popp
  • Patent number: 7674486
    Abstract: A composition for the treatment of diabetes in a subject in need thereof, comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.
    Type: Grant
    Filed: June 6, 2006
    Date of Patent: March 9, 2010
    Assignee: Indus Biotech Pvt. Ltd.
    Inventors: Sunil Bhaskaran, Vishwaraman Mihan
  • Patent number: 7674485
    Abstract: A composition for the treatment of diabetes in a subject in need thereof, said composition—comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: March 9, 2010
    Assignee: Indus Biotech Pvt. Ltd.
    Inventors: Sunil Bhaskaran, Vishwaraman Mohan
  • Publication number: 20100055172
    Abstract: Soy extracts encapsulated with oligosaccharides and processes for making the encapsulated soy extracts. The processes generally comprise combining a soy extract solution and an oligosaccharide solution to encapsulate the soy extract with the oligosaccharide, precipitation of the encapsulated soy extract solution to form sediment, centrifugation, ion exchange to remove ionic components and drying. Soy extracts encapsulated in the process include isoflavone derivatives, such as daidzin, glycitin, genistin, daidzein, glycitein and genistein, which may be encapsulated with ?r-cyclodextrin, ?-cyclodextrin, ?-cyclodextrin or combinations of these oligosaccharides.
    Type: Application
    Filed: November 1, 2007
    Publication date: March 4, 2010
    Inventor: Choi Yong Han
  • Patent number: 7670631
    Abstract: A method for the prevention of infection of humans by plasmodium parasites is provided. The method consists of the application of compounds that interfere with the infection of hepatocytes by Plasmodium viax.
    Type: Grant
    Filed: March 9, 2004
    Date of Patent: March 2, 2010
    Assignee: ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda.
    Inventors: Maria M. Mota, Ana Rodriguez, Silvia Giordano, Margarida Cunha Rodrigues
  • Patent number: 7670632
    Abstract: The invention provides saponin mixtures and compounds which are isolated from the species Acacia victoriae and methods for their use. These compounds may contain a triterpene moiety, such as acacic or oleanolic acid, to which oligosaccharides and monoterpenoid moieties are attached. The mixtures and compounds have properties related to the regulation of apoptosis and cytotoxicity of cells and exhibit potent anti-tumor effects against a variety of tumor cells.
    Type: Grant
    Filed: December 6, 2005
    Date of Patent: March 2, 2010
    Assignee: Research Development Foundation
    Inventors: Charles J. Arntzen, Mary E. Blake, Jordan U. Gutterman
  • Publication number: 20100047361
    Abstract: The invention relates to active principles which are capable of inducing the conversion of inactive TGFb-Latent into active TGFb. The invention relates in particular to the use of such an extract for the manufacture of a composition for increasing the concentration of active TGFb1 in the skin, notably in the dermis. The present invention also relates to the uses which are derived from said use, as well as to cosmetic or pharmaceutical compositions which comprise said extract.
    Type: Application
    Filed: November 6, 2009
    Publication date: February 25, 2010
    Applicants: BASF Beauty Care Solutions France S.A.S., Laboratoire de Dermocosmetique
    Inventors: Eric PERRIER, Cecile ALTOBELLI, Anne CLEMENT, Corinne REYMERMIER, Nabil ABDUL MALAK
  • Patent number: 7666451
    Abstract: A method of use for a topical herbal formulation alone or in combination with oral administration of niacin (preferably a flush preparation) to prevent and/or treat dyshidrosis (pompholyx) and related skin diseases. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders.
    Type: Grant
    Filed: January 11, 2008
    Date of Patent: February 23, 2010
    Inventors: Elizabeth Anne Mazzio, Karam F Soliman
  • Publication number: 20100040711
    Abstract: A method for prophylactically treating irritable bowel syndrome in a mammal through the administration of a zinc carnosine composition like zinc carnosine is provided, although other forms of zinc carnosine or other components exhibiting zinc carnosine activity like other metal carnosine complexes may be used. The effective amount of composition to be used will depend upon such factors as the age and weight of the mammal, and whether treatment of existing IBS symptoms, or prevention of the onset of IBS symptoms is desired. A complex comprising such a zinc carnosine composition for prophylactically treating IBS in a mammal is also provided.
    Type: Application
    Filed: May 4, 2009
    Publication date: February 18, 2010
    Inventors: Raymond J. Playford, David McLain
  • Publication number: 20100021571
    Abstract: This invention provides anti-acne kits that are useful for treating acne, especially severe cases of acne. The anti-acne kits include a vasoconstrictor and an anti-acne agent, and optionally one or more of a a skin lightening therapeutic, a sealing layer, a skin cleanser, an astringent, a skin penetration enhancer, a sunscreen, and nutritional supplements that promote healing of acne lesions. This invention also provides methods for treating acne using a vasoconstrictor in conjunction with an anti-acne agent.
    Type: Application
    Filed: March 30, 2006
    Publication date: January 28, 2010
    Applicant: Revance Therapeutics, Inc.
    Inventors: Jacob M. Waugh, Jae Hoon Lee
  • Patent number: 7651705
    Abstract: Provided herein are synergistic herbal compositions for the treatment of gastric ulcer, said composition essentially comprising powdered plant parts of Asparagus racemosus, Glycyrrhiza glabra, Sesamum indicum, Musa sapientum and Trachyspermum roxburghianum and optionally, powdered plant parts of Cyclea peltata, Embelia ribes, Coriandrum sativum Ferulaasafetida, Aloe barbadensis and Evolvulus aisinodes along with one or more pharmaceutically acceptable additives/carriers, processes for preparing such compositions and methods for treating gastric ulcers using such compositions.
    Type: Grant
    Filed: October 28, 2003
    Date of Patent: January 26, 2010
    Assignee: Council of Scientific & Industrial Research
    Inventors: Janaswamy Madhusudana Rao, Upparapalli Sampathkumar, Boggavarapu Subrahmanya Sastry, Jhillu Singh Yadav, Kondapuram Vijaya Raghavan, Gautam Palit, Dwaraka Nath Bhalla, Deepak Rai, Panniyampally Madhavankutty Varier, Trikovil Sankaran Muraleedharan, Kollath Muraleedharan
  • Publication number: 20100016833
    Abstract: Devices for the treatment of vascular aneurysms are described. The treatment is achieved through the delivery of an effective amount of elastin stabilization agent to an isolated volume at the aneurysm. The elastin stabilization agent maybe embedded in a delivery composition. The device optionally has an aspiration means to improve the effectiveness of the treatment.
    Type: Application
    Filed: July 15, 2008
    Publication date: January 21, 2010
    Inventors: Matthew F. Ogle, Jason C. Isenburg
  • Patent number: 7645467
    Abstract: The present invention provides a method for the preparation of a plant jelly in the form of a jelly-like product wherein selected phospholipids (for example, PC, PE and lyso-PC/PE) play an important role in jellifying the mixture. The plant jelly has a plant hard fat blend and an oil blend in which the plant hard fat blend is made up of about 10-20% of a fat with a melting point of 30-40° C. and about 4-10% of a vegetable fat, and in which the oil blend is made up of about 1-3.5% phospholipids and about 70-80% liquid oil.
    Type: Grant
    Filed: May 3, 2006
    Date of Patent: January 12, 2010
    Inventor: Firouz Jahaniaval
  • Patent number: 7645466
    Abstract: The present invention is directed to novel compositions of bio-active compounds comprising 4-hydroxyisoleucine and one or more compounds selected from the group of amino acids, alkaloids, glycosides, volatile oils, saponins, sapogenins, mannans, flavonoids, fatty acids, vitamins and provitamins, minerals, and carbohydrates. Preferably, the novel compositions of bio-active compounds include 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, omithine, proline, lysine, histidine, and gamma-aminobutyrate. The composition of bio-active compounds preferably include between about ten percent and about seventy percent of 4-hydroxyisoleucine and between about twenty percent and about forty percent of other amino acids.
    Type: Grant
    Filed: March 1, 2005
    Date of Patent: January 12, 2010
    Assignee: TSI Group Limited
    Inventors: Steve S. Lee, Richard B. Hynson, Ke-Qin Zhang, Wu-Zhou Li, Jing S. Zhou
  • Patent number: 7641925
    Abstract: A synergistic composition for the treatment of diabetes in a subject in need thereof, comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.
    Type: Grant
    Filed: February 15, 2006
    Date of Patent: January 5, 2010
    Assignee: Indus Biotech Pvt. Ltd.
    Inventors: Sunil Bhaskaran, Vishwaraman Mohan
  • Patent number: 7641924
    Abstract: A nutritional composition for controlling blood sugar level comprising a protein, a lipid and a carbohydrate, wherein energy percentages supplied by the protein, lipid and carbohydrate are 10 to 25%, 20 to 35% and 40 to 60%, respectively; and oleic acid in the lipid energy percentage is 60 to 90% and palatinose and/or trehalulose in the carbohydrate energy percentage is 60 to 100%. The composition is useful as an oral or tube feeding nutrient for nutritional management or blood sugar level control of patients suffering from diabetes and glucose intolerance, or for obesity prevention, a therapeutic diet, a diet for diabetic patients at home, an obesity preventive diet or a food with health claims.
    Type: Grant
    Filed: September 6, 2002
    Date of Patent: January 5, 2010
    Assignee: Meiji Dairies Corporation
    Inventors: Kenji Mizumoto, Hajime Sasaki, Hisae Kume, Makoto Yamaguchi
  • Patent number: 7635756
    Abstract: It is intended to improve the water-dispersibility of a soybean 7S protein isolate, which is rich in soybean 7S globulin as compared with a conventional soybean protein isolate, to thereby provide a beverage thereof easy to drink or ameliorate the workability thereof in producing processed food products such as dough products and tablets. The improved soybean 7S protein isolate having high water-dispersibility can be obtained by treating a soybean 7S protein fraction with an aqueous ethanol solution and drying the same followed by, if necessary, grinding or controlling the grain size. Further, the viscosity of an aqueous dispersion of the above protein isolate can be lowered by acidifying the same.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: December 22, 2009
    Assignee: Fuji Oil Company, Limited
    Inventors: Toshimitsu Baba, Ken Ishida
  • Publication number: 20090311353
    Abstract: An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc. The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.
    Type: Application
    Filed: December 5, 2006
    Publication date: December 17, 2009
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD
    Inventors: Hiroyuki Kimura, Takeshi Yamauchi, Tomomi Ueno, Toshimi Suzuki, Kentaro Tadano, Ikutaro Sato, Shigeto Uchiyama, Masahiro Oono, Masatoshi Mizuno
  • Publication number: 20090304831
    Abstract: An improved laxative composition is provided having efficacy with reduced negative side-effects. The laxative composition is also provided with agents that promote healthy intestinal and liver function, reduce carbohydrate absorption and have antioxidant capacity. A method is also provided for reducing the negative side-effects associated with Anthranoid-based laxative compositions. A method is further provided for increasing the efficacy and/or duration of effect of Anthranoid-based laxative compositions.
    Type: Application
    Filed: June 3, 2009
    Publication date: December 10, 2009
    Inventors: Ken CLEMENT, Marvin A. Heuer, William Ha, Megan Thomas, Erin Taraborrelli, Krista Rutherford
  • Patent number: 7629005
    Abstract: A pharmaceutical formulation of a calcium salt and a dry plant extract in the form of a coated tablet, in which the formulation has a core of at least one dry plant extract, enveloped by at least one coating of at least one calcium salt. The plant extracts for the core may be selected from: Vitex agnus castus (chaste tree); Belamcanda chinensis (leopard lily); Cimicifuga racemosa (black cohosh); Trifolium pratense L. (purple trefoil); Oenothera biennis hom. (primrose); Glycine soja (soy bean); Serenoa repens (saw-palmetto); Urtica dioica (stinging nettle), in particular its root; Cucurbita pepo (pumpkin), in particular its seed; Pygeum africanum; as well as suitable mixtures of these. Methods for the use of the formulation in treating osteoporosis and for manufacturing the formulation are provided.
    Type: Grant
    Filed: April 10, 2002
    Date of Patent: December 8, 2009
    Assignee: Bionorica AG
    Inventor: Michael A. Popp
  • Patent number: 7618485
    Abstract: Biodegradable compositions that include a foamed gelling hydrocolloid system to which a firming agent and a fibrous material, with or without other optional components, are added. When articles prepared from such compositions are coated with a suitable coating, they are impervious to boiling water and able to withstand microwave heating.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: November 17, 2009
    Assignee: The Biodegradable Technologies General Partnership
    Inventor: Donald W. Renn
  • Patent number: 7618672
    Abstract: The present invention relates to a process for selectively removing undesired oligosaccharides from aqueous mixtures such as plant processing waste products, including soy whey and other vegetable wheys, using an ultrastabilized large pore, hydrophobic zeolite Y. The resulting solution, which contains isoflavones and digestible sugars such as glucose, fructose and sucrose, can serve as the basis for a nutritious new product.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: November 17, 2009
    Assignee: E. I. du Pont de Nemours and Company
    Inventors: David Richard Corbin, Vasantha Nagarajan, Vidya Pai, Stuart M. Thomas
  • Patent number: 7618671
    Abstract: The present invention provides a process using zeolites for recovering isoflavones and removing undesired oligosaccharides from aqueous mixtures, such as soy whey and other plant processing waste products. The aqueous mixture is treated with a large pore hydrophobic zeolite, such as zeolite Beta, to remove isoflavones, followed by treatment with an ultrastabilized, hydrophobic zeolite Y, such as CBV-901 or HiSiv™ 4000, to remove the undesired oligosaccharides raffinose and stachyose. The recovered isoflavones and digestible sugars, glucose, sucrose, and fructose, are useful in food products.
    Type: Grant
    Filed: November 5, 2004
    Date of Patent: November 17, 2009
    Assignee: E.I. du Pont de Nemours and Company
    Inventors: David Richard Corbin, Vasantha Nagarajan, Vidya Pai, Stuart M. Thomas
  • Publication number: 20090280200
    Abstract: An herbal extract which induces immune cells to produce interferon and activates Toll-like receptors and a preparation method thereof are provided. The herbal extract is extracted from an effective amount of raw material including Glycyrrhizae Radix, Bupleuri Radix, Scutellariae Radix, Schisandrae Fructus and Paeoniae Rubra Radix. Glycyrrhizae Radix, Bupleuri Radix, Scutellariae Radix, Schisandrae Fructus and Paeoniae Rubra Radix have a weight ratio of 1-5:1-5:1-5:1-3:1-3.
    Type: Application
    Filed: June 30, 2008
    Publication date: November 12, 2009
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: I Horng PAN, Lain-Tze LEE, Chih-Lung CHEN, Hsin-Jan YAO, Chu-Hsun LU, Chen Hsuan LIN, Ya-Yan YANG, Hsin-Hsin SHEN, Ming-Feng CHEN
  • Patent number: 7615240
    Abstract: The present invention provides methods and compositions for controlling gastrointestinal parasitic infections in animals. More specifically, the invention involves the use of sericea lespedeza (Lespedeza cuneata), commonly referred to as Chinese bush clover, in the diet of animals to control nematodal gastrointestinal infections.
    Type: Grant
    Filed: January 6, 2006
    Date of Patent: November 10, 2009
    Assignee: Auburn University
    Inventors: Jorge A. Mosjidis, Thomas H. Terrill, James E. Miller, Joan M. Burke
  • Patent number: 7615239
    Abstract: Technical Field: Tea Technical Problem: To provide a drinkable tea having a high therapeutic effect against atopic dermatitis. Means for Solving: It is characterized in that it contains extracts drawn from one, two or more medicinal herbs selected from the group consisting of Lightyellow Sophora Root, Isatis Leaf, and Terminalia Fruit. Atopic dermatitis can be cured by improving allergic constitution from the inside of body owing to antibacterial effect and antiviral effect of Lightyellow Sophora Root, Isatis Leaf and Terminalia Fruit, antiallergic effect of Lightyellow Sophora Root and Isatis Leaf, and intestinal mucosal protecting effect of Terminalia Fruit, or by a synergistic effect of them.
    Type: Grant
    Filed: April 15, 2002
    Date of Patent: November 10, 2009
    Inventors: Tetsuo Santo, Songhua Li, Ruwei Wang, Sumio Iwasaki
  • Publication number: 20090258030
    Abstract: The subject invention provides methods for improving livestock health. In specific embodiments, the invention provides methods for accelerating and/or augmenting livestock growth; improving immunity; and enhancing fertility in livestock. To do so, the present invention provides materials and methods for administering a cysteamine compound to livestock.
    Type: Application
    Filed: January 22, 2007
    Publication date: October 15, 2009
    Inventors: Francis Chi, Gary Kwan Po Wong
  • Patent number: 7597911
    Abstract: A selection of herbal materials with curative effects combined in a liquid form and processed into a suitable topical delivery system for application to skin ulcerations, surgical incisions wounds and cuts to accomplish accelerated wound healing. The present invention can also heal and provide 1st and 2nd degree burn, radiation burn and sunburn relief and be used for application to human skin affected with psoriasis, eczema, dermatitis, acne, rosacea, extreme dryness, allergic reactions and inflammatory rashes. The process to manufacture and the herbal extract vehicle of delivery are both critical to the effectiveness of the present invention since the invention is comprised of two separate herbal composition extracts which do not form a homogenous mixture when combined.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: October 6, 2009
    Assignee: CuraPharm, Inc.
    Inventor: Thomas M. Hnat
  • Publication number: 20090247409
    Abstract: The present invention relates to stable, agricultural oil-in-water emulsion compositions.
    Type: Application
    Filed: March 9, 2009
    Publication date: October 1, 2009
    Applicant: DOW AGROSCIENCES LLC
    Inventors: Wen Xu, Holger Tank
  • Publication number: 20090232918
    Abstract: The present invention comprises compositions, methods and cell lines related to controlling insects. An embodiment of a composition comprises a plant essential oil and targets at least one receptor of insects chosen from tyramine receptor, Or83b olfactory receptor, and Or43a olfactory receptor, resulting in a change in the intracellular levels of cAMP, Ca2+, or both in the insects.
    Type: Application
    Filed: March 28, 2008
    Publication date: September 17, 2009
    Applicant: TyraTech, Inc.
    Inventor: Essam Enan
  • Publication number: 20090232919
    Abstract: The present invention is related to a composition comprising an extract of licorice or liquiritigenin isolated therefrom significantly decrease the blood concentration of LDH and ALT enzyme, central necrosis and inflammation in acetaminophen-induced hepato-toxicity animal model when the inventive extract or compound of the present invention was orally and intravenously administrated thereto.
    Type: Application
    Filed: January 5, 2007
    Publication date: September 17, 2009
    Inventors: Sang Geon Kim, Sang Chan Kim, Young Woo Kim
  • Patent number: 7588781
    Abstract: A primary composition that includes at least one lipophilic bioactive compound and a whey protein in an amount effective to increase the bioavailability of the lipophilic bioactive compound, and methods of forming the same. Also, an oral composition that contains the primary composition in a foodstuff, in a food supplement, in a cosmetic preparation or in a pharmaceutical preparation, and methods of forming the same.
    Type: Grant
    Filed: October 27, 2006
    Date of Patent: September 15, 2009
    Assignee: Nestec S.A.
    Inventors: Karlheinz Bortlik, Francoise Saucy, Eliane Duruz, Myriam Richelle, Pierre Lambelet, Markus Baur, Andrea M. A. Pfeifer
  • Publication number: 20090226551
    Abstract: A pharmaceutical composition for preventing and/or treating bone loss is disclosed. The pharmaceutical composition includes an effective amount of a licorice, black bean, Cnidi Fructus, and buckhorn.
    Type: Application
    Filed: March 7, 2008
    Publication date: September 10, 2009
    Inventors: Chao Hsiang CHEN, Mei-Yin Chien, Wen-Mei Fu, Jin-Ming Chang
  • Patent number: 7585526
    Abstract: Flexible elastomer articles and methods of making the same are disclosed in which a material, a botanical extract, is incorporated into an elastomer emulsion, solution and/or plastisol in order to enhance the physical and therapeutic properties of articles made from these materials. In another aspect, the invention relates to coating surfaces of flexible elastomer articles with a non-Aloe vera mucinous botanical or laboratory produced polysaccharide which is fortified by additives known to protect, restore and moisturize mammalian skin or mucosa and to enhance ease of application or donnability of the article. Flexible elastomer articles include gloves and other single layer or multi-layer flexible elastomer articles.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: September 8, 2009
    Assignee: Smarthealth, Inc.
    Inventor: Curtis P. Hamann
  • Patent number: 7582307
    Abstract: Dermatological compositions containing a humectant, e.g., at least one of urea, ammonium lactate, and glycerin, and an emollient, e.g., at least one of Shea or cocoa butter, glycine soja sterol and hybrid sunflower oil. The compositions of the invention may be utilized for treatment or amelioration of skin disorders or adverse physiological conditions, and such compositions may be employed as a base for cosmetic or pharmaceutical formulations for dermal administration.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: September 1, 2009
    Assignee: Harmony Labs, Inc.
    Inventor: Bruce Kevin Wagoner
  • Publication number: 20090214681
    Abstract: A method for treating a disease or disorder associated with retinal pigment epithelium (RPE) disturbance, comprising administering to a human in need thereof an effective amount of a black soybean (Glycine max (L.) Merr) product is provided, wherein the black soybean product is the seed coats of black soybean or an alcoholic extract of black soybean or seed coats thereof.
    Type: Application
    Filed: February 25, 2008
    Publication date: August 27, 2009
    Inventor: Rong-Tsun Wu
  • Patent number: 7579027
    Abstract: The present invention is for composition containing extract of Northern White Kidney Bean (Phaseolus vulgaris), extract of Red Kidney Bean (Phaseolus vulgaris) and extract of Green Tea (Camellia Sinensis ). This invention as a supplemental compound, aids in weight reduction both in overweight and obese individuals. This invention helps normal weight subjects in improving their quality of life by maintaining their normal weight. Included is also folic acid, (B6) and B12 and the whole supplement is bound by a vegetable matrix. The present invention is directed to methods for inducing weight loss by inhibit the absorption of dietary lipids and starch, increase the metabolic rate and decrease the amino acid homocysteine in the blood, an amino acid known to cause risk of heart disease, by administering a composition of the invention. Due to the content of the green tea extract this invention is also meant to reduce and prevent occurrence of gastrointestinal cancer and cancer of the prostate.
    Type: Grant
    Filed: September 20, 2005
    Date of Patent: August 25, 2009
    Inventor: Grethe Stoa Birketvedt
  • Patent number: 7572470
    Abstract: Described are a plurality of risk factors that may be treated and conditions that may be prevented and treated by administering to a patient a preparation containing a licorice extract, which is water insoluble and free from glycyrrhizinic acid. Risk factors that may be lowered include hypertension, high blood glucose concentration, LDL susceptibility to retention, LDL susceptibility to aggregation, blood total cholesterol and LDL levels, and blood tryglicerides and VLDL concentration. Conditions and diseases that may be treated according to the invention include aterosclerotic diseases, hypertension, cardiovascular diseases, chronic renal failure, carotid artery stenosis, coronary heart diseases, hypercholesterolemia, and hypertriglyceridemia.
    Type: Grant
    Filed: September 20, 2001
    Date of Patent: August 11, 2009
    Assignee: Ready-Made 37 Ltd.
    Inventors: Luba Cohen, Michael Aviram
  • Patent number: 7566461
    Abstract: Novel materials for controlling molluscs, such as snails and slugs, using carbohydrates including celluloses, hemicellulose complexes, and/or lignin, for inducing death in molluscs. The materials are non-toxic, will not contaminate a drinking water supply, will not harm fish, birds or wild life, will not cause any harmful effects if swallowed or absorbed through the skin, will not harm children or pets, and can be safely eaten by domestic animals and livestock that may consume such dead molluscs. The materials may be applied in various formulations at various water contents. The materials do not provide nutrition to the molluscs, and disrupt normal bodily functions resulting in death. An attractant may be included to encourage ingestion by the molluscs.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: July 28, 2009
    Assignee: Sci Protek, Inc.
    Inventor: Nigel Grech
  • Patent number: 7563464
    Abstract: A composition and method for direct application to mucosal membranes, which combines naturally occurring phytoestrogens, such as plant extracts and soy isoflavones, with other active and inactive ingredients in a convenient medium, such as an aqueous cream, aqueous spray or suppository. The composition may be used for the treatment of dry or inadequately hydrated mucosal surfaces, and related complications, such as those affecting the nasal passages or vagina.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: July 21, 2009
    Inventors: Bruce Eric Hudkins, Thomas G. Matkov
  • Publication number: 20090181111
    Abstract: The invention is related to methods and compositions for reducing protozoa populations in animals. In an embodiment, the invention includes a method for reducing protozoal populations including administering a first composition comprising an effective amount of saponins to the animal, and administering a second composition comprising an effective amount of a preservative to the animal. In an embodiment, the invention includes a method for killing protozoa comprising contacting protozoa with a composition comprising an effective amount of saponins and an effective amount of ethoxyquin. Other embodiments are included herein.
    Type: Application
    Filed: October 15, 2008
    Publication date: July 16, 2009
    Inventors: Larry C. McNeff, Clayton V. McNeff, Peter G. Greuel
  • Publication number: 20090175969
    Abstract: A formulation for treating obesity and associated metabolic syndrome. The formulation is a combination of especially selected vegetable extracts: Green tea extract containing epigallocatechin galate (EGCG), Coleus forskholii extract, Betula alba extract, and Guarana or Yerba Maté extract. Based upon clinical in vivo and in vitro studies, use of the formulation was found to help in the treatment of obesity and associated co-morbidities. One of the most important advantages of the formulation of the invention, apart from the acceleration of weight loss, is the prevention of weight regain after the termination of a slimming cure.
    Type: Application
    Filed: January 12, 2005
    Publication date: July 9, 2009
    Applicant: BRINGWELL INTERNATIONAL AB
    Inventor: Marcin Krotkiewski
  • Patent number: 7556828
    Abstract: A pharmaceutical composition with higher curative effect on benign prostate hyperplasia and emiction disorders. It uses plants such as ginseng and ginkgo as well as cassia twig, cinnamon and liquorices as raw materials in both food and medicine. These raw materials are decocted or extracted separately in ethanol solution or water, then concentrated and dried to make the said pharmaceutical composition. Because this pharmaceutical composition is not toxic and has no side effect, it can be prepared as a medicament and health food to treat and improve benign prostate hyperplasia and emiction disorders caused by benign prostate hyperplasia.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: July 7, 2009
    Inventors: Zuguang Zhang, Yufen Wang